165 related articles for article (PubMed ID: 20010943)
1. Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells.
Johansson D; Andersson C; Moharer J; Johansson A; Behnam-Motlagh P
Br J Cancer; 2010 Jan; 102(2):383-91. PubMed ID: 20010943
[TBL] [Abstract][Full Text] [Related]
2. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
[TBL] [Abstract][Full Text] [Related]
3. Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines.
Johansson D; Johansson A; Grankvist K; Andersson U; Henriksson R; Bergström P; Brännström T; Behnam-Motlagh P
Cancer Biol Ther; 2006 Sep; 5(9):1211-7. PubMed ID: 16929170
[TBL] [Abstract][Full Text] [Related]
4. alpha-Toxin of Staphylococcus aureus overcomes acquired cisplatin-resistance in malignant mesothelioma cells.
Johansson D; Johansson A; Behnam-Motlagh P
Cancer Lett; 2008 Jun; 265(1):67-75. PubMed ID: 18362050
[TBL] [Abstract][Full Text] [Related]
5. Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis.
Johansson D; Kosovac E; Moharer J; Ljuslinder I; Brännström T; Johansson A; Behnam-Motlagh P
BMC Cancer; 2009 Feb; 9():67. PubMed ID: 19245689
[TBL] [Abstract][Full Text] [Related]
6. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
7. Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance.
Janson V; Johansson A; Grankvist K
Cell Death Dis; 2010 Sep; 1(9):e78. PubMed ID: 21364680
[TBL] [Abstract][Full Text] [Related]
8. Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.
Behnam-Motlagh P; Tyler A; Grankvist K; Johansson A
Toxins (Basel); 2010 Oct; 2(10):2467-77. PubMed ID: 22069561
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
[TBL] [Abstract][Full Text] [Related]
10. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
[TBL] [Abstract][Full Text] [Related]
12. Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.
Kitazono-Saitoh M; Takiguchi Y; Kitazono S; Ashinuma H; Kitamura A; Tada Y; Kurosu K; Sakaida E; Sekine I; Tanabe N; Tagawa M; Tatsumi K
Oncol Rep; 2012 Jul; 28(1):33-40. PubMed ID: 22562354
[TBL] [Abstract][Full Text] [Related]
13. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
14. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.
Denis I; Cellerin L; Gregoire M; Blanquart C
Oncotarget; 2014 Nov; 5(22):11641-52. PubMed ID: 25361002
[TBL] [Abstract][Full Text] [Related]
17. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C
Lung Cancer; 2018 Jun; 120():34-45. PubMed ID: 29748013
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of cisplatin-resistance in malignant mesothelioma cells abrogates Na+,K+,2Cl(-)-cotransport activity and cisplatin-induced early membrane blebbing.
Janson V; Andersson B; Behnam-Motlagh P; Engström KG; Henriksson R; Grankvist K
Cell Physiol Biochem; 2008; 22(1-4):45-56. PubMed ID: 18769031
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.
Ozvaran MK; Cao XX; Miller SD; Monia BA; Hong WK; Smythe WR
Mol Cancer Ther; 2004 May; 3(5):545-50. PubMed ID: 15141012
[TBL] [Abstract][Full Text] [Related]
20. Effect of citrate on malignant pleural mesothelioma cells: a synergistic effect with cisplatin.
Zhang X; Varin E; Allouche S; Lu Y; Poulain L; Icard P
Anticancer Res; 2009 Apr; 29(4):1249-54. PubMed ID: 19414371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
